We welcome universities, biotechs, startups, and researchers at home and abroad
who have innovative ideas and technologies.
Join Daewoong Pharmaceutical in developing global innovative medicines that improve quality of life,
and be part of the journey to share in that success.
Please share your ideas.
Daewoong Pharmaceutical turns them into reality.
Daewoong Pharmaceutical collaborates with promising partners through its differentiated pharmaceutical and biotech collaboration programs and customized package programs tailored to each startup stage.
01 Acceleration programs by company growth stage
Startup support, seed investment support, investment linked to the Southeastern New Deal Fund
Global expansion consulting through a bio global network (e.g., Harbour BioMed, Roivant) and a network of 10 overseas branches
Daewoong Open-LABs in Yongin and Gyeongnam, as well as smart office spaces in Samseong-dong, Hangang ferry terminal, Yongin, and Magok.
growth factor and stem cell-based nonclinical/clinical candidate libraries
JV formation, research institute spin-offs, in-house venture establishment, strategic follow-on investment, and manufacturing/marketing partnerships
02 Daewoong Pharmaceutical’s Venture Incubation Program: INNOBEAR Competition
The INNOBEAR Competition is a practical win-win program that identifies promising partners at an early stage and
turns their ideas into real innovative new drugs through the strong support of the Daewoong Group.
Through this competition each year, Daewoong supports promising pre-entrepreneurs, early-stage TIPS investment,
and follow-up acceleration.
Daewoong is creating innovations for human health together with partners with expertise in diverse fields.